Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andrew D Hamilton

Showing results (141-150 of 180) with videos related to

Pageof 18
Sort By:
Molecular Cancer Therapeutics|March 18, 2004
Novel peptidomimetic inhibitors of signal transducer and activator of transcription 3 dimerization and biological activityJames Turkson, Joon S Kim, Shumin Zhang, et al.
The Journal of Biological Chemistry|February 13, 2002
Inhibition of protein geranylgeranylation and RhoA/RhoA kinase pathway induces apoptosis in human endothelial cellsXianwu Li, Li Liu, Joan C Tupper, et al.
Bioorganic & Medicinal Chemistry Letters|November 22, 2005
Optimization of diarylamines as non-nucleoside inhibitors of HIV-1 reverse transcriptaseJuliana Ruiz-Caro, Aravind Basavapathruni, Joseph T Kim, et al.
Cancer Letters|December 27, 2005
Differential effects of Stat3 inhibition in sparse vs confluent normal and breast cancer cellsAikaterini Anagnostopoulou, Adina Vultur, Rozanne Arulanandam, et al.
Oncogene|September 19, 2003
Farnesyltransferase inhibitors are potent lung cancer chemopreventive agents in A/J mice with a dominant-negative p53 and/or heterozygous deletion of Ink4a/ArfZhongqiu Zhang, Yian Wang, Laura E Lantry, et al.
Molecular and Cellular Biology|September 19, 2007
Geranylgeranyltransferase I inhibitors target RalB to inhibit anchorage-dependent growth and induce apoptosis and RalA to inhibit anchorage-independent growthSamuel C Falsetti, De-an Wang, Hairuo Peng, et al.
Bioorganic & Medicinal Chemistry Letters|August 26, 2006
Optimization of pyrimidinyl- and triazinyl-amines as non-nucleoside inhibitors of HIV-1 reverse transcriptaseVinay V Thakur, Joseph T Kim, Andrew D Hamilton, et al.
Journal of the American Chemical Society|November 30, 2006
FEP-guided selection of bicyclic heterocycles in lead optimization for non-nucleoside inhibitors of HIV-1 reverse transcriptaseJoseph T Kim, Andrew D Hamilton, Christopher M Bailey, et al.
Chembiochem : a European Journal of Chemical Biology|November 14, 2008
Targeting protein-protein interactions: suppression of Stat3 dimerization with rationally designed small-molecule, nonpeptidic SH2 domain bindersPatrick T Gunning, Matthew P Glenn, Khandaker A Z Siddiquee, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 4, 2011
Combination of farnesyltransferase and Akt inhibitors is synergistic in breast cancer cells and causes significant breast tumor regression in ErbB2 transgenic miceMaria E Balasis, Kara D Forinash, Y Ann Chen, et al.
Pageof 18

Showing results (141-150 of 180) with videos related to

Sort By:
Pageof 18
Molecular Cancer Therapeutics|March 18, 2004
Novel peptidomimetic inhibitors of signal transducer and activator of transcription 3 dimerization and biological activityJames Turkson, Joon S Kim, Shumin Zhang, et al.
The Journal of Biological Chemistry|February 13, 2002
Inhibition of protein geranylgeranylation and RhoA/RhoA kinase pathway induces apoptosis in human endothelial cellsXianwu Li, Li Liu, Joan C Tupper, et al.
Bioorganic & Medicinal Chemistry Letters|November 22, 2005
Optimization of diarylamines as non-nucleoside inhibitors of HIV-1 reverse transcriptaseJuliana Ruiz-Caro, Aravind Basavapathruni, Joseph T Kim, et al.
Cancer Letters|December 27, 2005
Differential effects of Stat3 inhibition in sparse vs confluent normal and breast cancer cellsAikaterini Anagnostopoulou, Adina Vultur, Rozanne Arulanandam, et al.
Oncogene|September 19, 2003
Farnesyltransferase inhibitors are potent lung cancer chemopreventive agents in A/J mice with a dominant-negative p53 and/or heterozygous deletion of Ink4a/ArfZhongqiu Zhang, Yian Wang, Laura E Lantry, et al.
Molecular and Cellular Biology|September 19, 2007
Geranylgeranyltransferase I inhibitors target RalB to inhibit anchorage-dependent growth and induce apoptosis and RalA to inhibit anchorage-independent growthSamuel C Falsetti, De-an Wang, Hairuo Peng, et al.
Bioorganic & Medicinal Chemistry Letters|August 26, 2006
Optimization of pyrimidinyl- and triazinyl-amines as non-nucleoside inhibitors of HIV-1 reverse transcriptaseVinay V Thakur, Joseph T Kim, Andrew D Hamilton, et al.
Journal of the American Chemical Society|November 30, 2006
FEP-guided selection of bicyclic heterocycles in lead optimization for non-nucleoside inhibitors of HIV-1 reverse transcriptaseJoseph T Kim, Andrew D Hamilton, Christopher M Bailey, et al.
Chembiochem : a European Journal of Chemical Biology|November 14, 2008
Targeting protein-protein interactions: suppression of Stat3 dimerization with rationally designed small-molecule, nonpeptidic SH2 domain bindersPatrick T Gunning, Matthew P Glenn, Khandaker A Z Siddiquee, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 4, 2011
Combination of farnesyltransferase and Akt inhibitors is synergistic in breast cancer cells and causes significant breast tumor regression in ErbB2 transgenic miceMaria E Balasis, Kara D Forinash, Y Ann Chen, et al.
Pageof 18